Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine Response and Biogenic Amines in Schizophrenia

NCT00169039 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.

NCT NCT00169039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine Response and Biogenic Amines in Schizophrenia
Lead sponsor
Harvard Medical School (HMS and HSDM)
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 1994
Completion date
February 28, 2002
Enrollment
66
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia